LOS ANGELES, CA / ACCESSWIRE / February 3, 2020 / MCTC Holdings, Inc. (OTC PINK:MCTC), a cannabinoid science forward company developing unique hemp infusion technologies, is pleased to announce it has added cannabis industry veteran, Mr. Robert L. Hymers III, as its Chief Financial Officer. Mr. Hymers, a current director of the Company, brings with him an extensive background in corporate finance, treasury, financial planning and analysis, tax, investor relations, strategic planning and risk management along with a deep understanding of the hemp and cannabis industries.
“The addition of Robert Hymers to the management team significantly strengthens our Company. He brings a unique combination of financial knowledge, executive insight and managerial talent that will help us not only in financial reporting and compliance, but also relative to both strategic planning and tactical execution. We welcome Robert to his new role with the MCTC family,” commented Arman Tabatabei, Chief Executive Officer.
Mr. Hymers is the Managing Partner of Pinnacle Tax Services in Los Angeles and was previously Chief Financial Officer and Director of Marijuana Company of America, Inc. (OTC: MCOA) and has significant experience in matters concerning tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance. Mr. Hymers holds a Master of Science in Taxation and a Bachelor’s of Science in Accountancy, in addition to a CPA license.
Regarding the appointment as MCTC’s Chief Financial Officer, Mr. Hymers said, “I am honored with my new role with MCTC. We are bringing not only unique intellectual property to the hemp extract and cannabis marketplaces, but we are also beginning to introduce highly innovative products based on our IP. It’s an exciting time in the marketplace and I am looking forward to helping the Company achieve its objectives while seeking to maximize shareholder value.”
The Company has recently filed six patents on hemp extract technologies and delivery systems. As previously announced, the Company plans to continue other areas of delivery systems research including its programs pertaining to cannabinoid glycosides, polymeric cannabinoid nanoparticles and nanofibers, and its hemp extract-based alcohol replacement technologies. The Company has also recently announced a new research project named THC-V Skinny Cannabinoid Project Varin for THC-V infusions, nanoparticles, and nanofibers, which it is in the process of launching.
About MCTC Holdings, Inc.
MCTC Holdings, Inc. (d/b/a: Cannabis Global) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector and its intent to change its corporate identity to Cannabis Global, Inc. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs.
More information on the Company can be viewed at www.CannabisGlobalinc.com.
For more information, please contact:
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.
SOURCE: MCTC Holdings, Inc
View source version on accesswire.com: